PRPO

Precipio Inc
NASDAQHEALTHCAREDIAGNOSTICS & RESEARCH

Key Statistics

Market Cap
$45.49M
P/E Ratio
EPS
$-0.45
Beta
1.28
52W High
$33.63
52W Low
$13.02
50-Day MA
$25.50
200-Day MA
$23.90
Dividend Yield
Profit Margin
-3.57%
Forward P/E
15.43
PEG Ratio
0.00

About Precipio Inc

Precipio, Inc., a cancer diagnostic and reagent technology company, provides diagnostic products and services in the United States oncology market. The company is headquartered in New Haven, Connecticut.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$25.83M
Gross Profit (TTM)$11.29M
EBITDA-356,000
Operating Margin-21.30%
Return on Equity-7.13%
Return on Assets-5.74%
Revenue/Share (TTM)$15.42
Book Value$7.94
Price-to-Book3.19
Price-to-Sales (TTM)1.76
EV/Revenue1.782
EV/EBITDA49.34
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)36.20%
Shares Outstanding$1.79M
Float$1.41M
% Insiders12.59%
% Institutions17.66%

Historical Volatility

HV 10-Day
33.43%
HV 20-Day
32.65%
HV 30-Day
36.39%
HV 60-Day
55.70%
HV Rank
2.0%

Volatility is currently contracting

Latest News

Precipio to Present at the Planet MicroCap Las Vegas

NEW HAVEN, Conn., June 11, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc. (NASDAQ: PRPO) , announces that it will be presenting at the Planet MicroCap Las Vegas 2026 on Wednesday, June 17, 2026, at 9:00 AM (Local Time, 12:00pm EST) at the Bellagio Resort & Hotel. Ilan Danieli, CEO and Zaki Sabet, COO of Precipio will be hosting the presentation and answering questions at the conclusion.

GlobeNewsWire6/11/2026Neutral
Precipio Announces Q1-2026 Shareholder Update Call

NEW HAVEN, Conn., May 06, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.   (NASDAQ: PRPO) , will be hosting its Q1-2026 shareholder update call on May 18th, 2026, at 5:00 PM ET.

GlobeNewsWire5/6/2026Neutral

More HEALTHCARE Stocks

Data last updated: 7/9/2026